NASDAQ:CYRN - Cyren Stock Price, Forecast & News

Cyren trades on the NASDAQ under the ticker symbol "CYRN."

Cyren Ltd (NASDAQ:CYRN) posted its quarterly earnings data on Wednesday, November, 13th. The technology company reported ($0.06) EPS for the quarter, topping the Zacks' consensus estimate of ($0.07) by $0.01. The technology company had revenue of $9.50 million for the quarter, compared to the consensus estimate of $9.80 million. Cyren had a negative return on equity of 68.95% and a negative net margin of 47.56%. View Cyren's Earnings History.

Cyren is scheduled to release their next quarterly earnings announcement on Wednesday, February 26th 2020. View Earnings Estimates for Cyren.

1 analysts have issued 1-year target prices for Cyren's shares. Their forecasts range from $3.00 to $3.00. On average, they expect Cyren's stock price to reach $3.00 in the next twelve months. This suggests a possible upside of 175.2% from the stock's current price. View Analyst Price Targets for Cyren.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cyren in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Cyren.

Media headlines about CYRN stock have trended very negative on Tuesday, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Cyren earned a media sentiment score of -3.0 on InfoTrie's scale. They also assigned news headlines about the technology company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Cyren.

Cyren saw a decrease in short interest in the month of January. As of January 31st, there was short interest totalling 10,600 shares, a decrease of 30.3% from the January 15th total of 15,200 shares. Based on an average trading volume of 30,300 shares, the days-to-cover ratio is presently 0.3 days. Currently, 0.0% of the shares of the company are short sold. View Cyren's Current Options Chain.

Some companies that are related to Cyren include Iclick Interactive Asia Group (ICLK), Smith Micro Software (SMSI), SharpSpring (SHSP), MAM Software Group (MAMS), Inspired Entertainment (INSE), Medical Transcription Billing (MTBC), Great Elm Capital Group (GEC), Aware (AWRE), Where Food Comes From (WFCF), Mobivity (MFON), NetSol Technologies (NTWK), Astea International (ATEA), Rego Payment Architectures (RPMT), CLPS (CLPS) and Audioeye (AEYE).

Based on aggregate information from My MarketBeat watchlists, some companies that other Cyren investors own include Actinium Pharmaceuticals (ATNM), NovaBay Pharmaceuticals (NBY), Athersys (ATHX), Biocept (BIOC), Inovio Pharmaceuticals (INO), Onconova Therapeutics (ONTX), AVEO Pharmaceuticals (AVEO), Co-Diagnostics (CODX), Corbus Pharmaceuticals (CRBP) and Inpixon (INPX).

Cyren's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Warburg Pincus LLC (54.30%), Renaissance Technologies LLC (1.14%), Belpointe Asset Management LLC (0.89%) and Meitav Dash Investments Ltd. (0.71%). Company insiders that own Cyren stock include Atif Ahmed, Joseph Michael Myshrall, Lior Samuelson and Sigurdur Arnar Stefnisson. View Institutional Ownership Trends for Cyren.

CYRN stock was sold by a variety of institutional investors in the last quarter, including Meitav Dash Investments Ltd.. View Insider Buying and Selling for Cyren.

CYRN stock was purchased by a variety of institutional investors in the last quarter, including Warburg Pincus LLC, Renaissance Technologies LLC and Belpointe Asset Management LLC. View Insider Buying and Selling for Cyren.

Shares of CYRN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CYRN stock can currently be purchased for approximately $1.09.

Cyren has a market capitalization of $64.66 million and generates $35.90 million in revenue each year. The technology company earns $-19,410,000.00 in net income (profit) each year or ($0.31) on an earnings per share basis. Cyren employs 248 workers across the globe.View Additional Information About Cyren.

The official website for Cyren is http://www.cyren.com/.

Cyren's mailing address is 10 Ha-Menofim St. 5th Floor, Herzliya L3, 4672561. The technology company can be reached via phone at 972-9863-6888 or via email at [email protected]